Moderator
Rosario Pivonello, MD, PhD
Federico II University, Italy
Presentations in This Video
Long-Term Control of Urinary Free Cortisol With Osilodrostat in Patients With Cushing's Disease: Final Results From the LINC 2 Study
Maria Fleseriu, MD
Oregon Health & Science University, OR, United States
Antisense Oligonucleotides as a Novel Therapy for Cushing's Disease
Hanan Eltumi, MBchB, MRes
University of Sheffield, United Kingdom
Pharmacokinetics and Safety of an Improved Oral Formulation of Paltusotine, a Selective, Non-Peptide Somatostatin Receptor 2 (SST2) Agonist for the Treatment of Acromegaly
Ajay Madan, PhD
Crinetics Pharmaceuticals, Inc., CA, United States
Canine Pituitary Organoids as 3D <i>In Vitro </i>Model for Cushing Disease
Karin Sanders, DVM, PhD
Faculty of Veterinary Medicine, Utrecht University, Netherlands
Outcome of Petrosal Venous Sampling in Consecutive 68 Patients From a Major Neurosurgical Center in the United Kingdom
Ziad Hussein, MRCP
University College London Hospitals NHS Foundation Trust, United Kingdom